Ignacio del Castillo Velilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ignacio del Castillo Velilla has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Aida Felipe Villalobos
Unidad de Cuidados Intensivos Pediátricos, Hospital Sant Joan de Deu, Barcelona, Spain
1 shared publication- Aida Felipe-Villalobos
Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain
1 shared publication Edurne Sarrate Garcia
Laboratorio de Hematología, Hospital Sant Joan de Déu, Barcelona, Spain
1 shared publication- Iolanda Jordan
Pediatric Infectious Diseases and Microbiome Research Group Institut de Recerca Sant Joan de Deu Barcelona Spain
1 shared publication - Lluïsa Hernandez-Platero
Pediatric Intensive Care Unit, Hospital Sant Joan de Deu, Universitat de Barcelona (UB), Passeig Sant Joan de Deu, 2, 08950 Barcelona, Spain
1 shared publication María Solsona Gadeaz
Hematología Pediátrica, Hospital Sant Joan de Déu, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 11 April 2025
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 102 (4) , 503765
Craniofacial lession as a presentation of idiopathic purpura fulminans
- 11 April 2025
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 102 (4) , 503765
Open AccessCraniofacial lession as a presentation of idiopathic purpura fulminans
- Open Access
Severe Juvenile-Onset Systemic Lupus Erythematosus: A Case Series-Based Review and Update
Juvenile-onset systemic lupus erythematosus (jSLE) is a multisystemic disease diagnosed in young patients based on the clinical criteria of the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). The importance of this condition lies in its greater aggressiveness compared with lupus diagnosed during adulthood (aSLE). Management, which is based on supportive care and immunosuppressive drugs, aims to reduce the overall disease activity and to prevent exacerbation. Sometimes the onset is accompanied by life-threatening clinical conditions. In this paper, we introduce three recent cases of jSLE that required admission to the Pediatric Intensive Care Unit (PICU) of a Spanish pediatric hospital. This manuscript aims to review some of the main complications associated with jSLE, such as diffuse alveolar hemorrhage, cerebral vasculitis, or an antiphospholipid syndrome; these are life-threatening conditions but they have a chance of favorable prognosis if treated early and aggressively.
Open AccessSevere Juvenile-Onset Systemic Lupus Erythematosus: A Case Series-Based Review and Update
Juvenile-onset systemic lupus erythematosus (jSLE) is a multisystemic disease diagnosed in young patients based on the clinical criteria of the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). The importance of this condition lies in its greater aggressiveness compared with lupus diagnosed during adulthood (aSLE). Management, which is based on supportive care and immunosuppressive drugs, aims to reduce the overall disease activity and to prevent exacerbation. Sometimes the onset is accompanied by life-threatening clinical conditions. In this paper, we introduce three recent cases of jSLE that required admission to the Pediatric Intensive Care Unit (PICU) of a Spanish pediatric hospital. This manuscript aims to review some of the main complications associated with jSLE, such as diffuse alveolar hemorrhage, cerebral vasculitis, or an antiphospholipid syndrome; these are life-threatening conditions but they have a chance of favorable prognosis if treated early and aggressively.